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Dye doped Nanoparticles in Biomedical Diagnostics. 
 
Vladimir Gubala  
 Biomedical Diagnostics Institute, Dublin City University, Glasnevin, Dublin 9, 
Ireland 
Synonyms 
Dye doped nanospheres in Biomedical Diagnostics 
 
Definition 
Dye doped nanoparticles are new class of fluorescent labels. They are typically 
made of silica or polystyrene with tens of thousands of fluorescent dyes 
entrapped in the pores of its polymer matrix. 
 
Overview and general concept 
 
When designing devices for biomedical diagnostics, it is essential to maximize 
the signal to noise ratio to achieve clinically relevant sensitivity and limits of 
detection. Simple assay designs involve first capturing an antigen onto a surface 
using one antibody, then measuring the surface concentration by visualizing the 
captured antigen through its reaction with a second, labeled antibody. There is 
increasing interest in fluorescence-based array sensors (biochips) for biomedical 
applications. While fluorescence detection offers high sensitivity, there is 
generally a low level of fluorescence signal from the biochip due to a monolayer 
of fluorescent labels, hence the importance of enhancing the fluorescence. In 
antibody-based assays, the measured signal can be amplified through the 
replacement of molecular luminophore with doped nanoparticles (NP) (Fig. 1). 
 
Fluorescent labels are used for a range of applications including immunosorbent 
assays(1), immunocytochemistry(2), flow cytometry(3) and DNA/protein 
microarray analysis(4). Current research in biomedical diagnostics is moving to 
inexpensive devices, using biochips that often have to measure biomolecules 
concentrations at the picomolar level in blood sample volumes on the microliter 
scale, without the possibility of any user manipulation of the sample. This is 
exceptionally challenging to achieve in a miniature bioassay device. First, the 
active biomolecules (antibody or nucleic acid) must be immobilized at the 
appropriate surface density while maintaining its reactivity. Second, the 
measured signal should be maximized relative to noise and background 
contributions. In antibody-based assays, non-specific binding (NSB) controls the 
background response and often results in a detection limit that is much higher 
than that defined by the equilibrium constants for the binding events.  
 
Figure 1 A cartoon illustrating the concept of fluorescence linked immunosorbent 
assay using the detection antibody labeled with molecular fluorophore (NIR-664 
in this particular case) and 80 nm nanoparticles, doped with tens of thousands of 
molecular dye molecules, thus significantly increasing the brightness of the label. 
The TEM image shows the high monodispersity and size-uniformity of 80 nm 
silica nanoparticles doped with NIR-664, prepared by reverse microemulsion 
method. Inset with PAMAM dendrimer highlights an unique modification of the 
NP surface that ensures high colloidal stability and efficient bioconjugation to 
biomolecules of interest. 
 
To meet these new demands, fluorescent labels with improved physical and 
chemical properties are required: for example, high photostability and 
fluorescence intensity, with a reproducible signal under a variety of chemical and 
biological conditions. Excellent photostability and significant reductions in 
photobleaching is required for applications where high intensity of prolonged 
excitations are applied, such as intracellular optical imaging. Dye-doped 
nanoparticles (typically silica or polystyrene) stand out as excellent candidates as 
it is possible to dope silica NPs with a large number of fluorophores, increasing 
the total fluorescence of the label significantly. Despite the effect of fluorescence 
quenching phenomena within an NP with a large amount of dye incorporated in a 
small volume, the goal of producing a particle with brighter fluorophores 
protected inside an organic matrix, thereby increasing photostability and quantum 
efficiency is largely successful. Owing to their intense signal, fluorescent 
nanoparticles (NP) are useful as labels since they can be measured directly, 
without the need for any amplification step. 
 
How to select appropriate dye doped NPs for your application? 
Dye doped NPs are currently offered in wide range of sizes, with entrapped 
fluorophores covering most of the useful spectrum of UV/Vis radiation and with a 
surface modification to contain chemically reactive groups, usually –COOH and –
NH2. Most of the scientists using dye doped NPs will make their decision based 
on the characteristics of the instrument (e.g. excitations source and emission 
filters) and the type of application. 
Typically, at least three parameters should be defined when selecting the 
appropriate dye doped NP: 
a) What is the desired fluorescence property of the NP for your application? 
The choice of the luminophore, particularly its excitation and emission 
wavelengths, obviously depends on the capacity of the instrument that is used to 
excite the fluorophores and collect the emitted light. However, it also depends on 
the application. At near infrared wavelengths there is low background 
interference from the fluorescence of biological molecules, solvent, and 
substrates. For example, whole blood has a weak absorption in the NIR region, 
thus reducing the need for whole-blood filtering for assays using whole blood. 
NIR light can also penetrate skin and tissue to several millimeters and this can 
enable fluorescence detection in dermatological or in-vivo diagnostic devices. 
When preparing dye doped NPs, it is also important to remember that not every 
readily available dye can be doped into the NP matrix. This will be further 
discussed later in this chapter. 
b) What is the desired size of the NP for your application? 
In case of bioassays, the answer to this question is specific to the design of the 
assay. While it is tempting to think that the brightness will increase with increased 
size of the NP, one must also consider the increased surface area and different 
monolayer packing arrangement of larger NP when compared to smaller ones. 
Figure 2 A computer model showing the correlation between the brightness ratio 
and the radius and number of dye molecules entrapped inside NP. 
 
It is not necessarily true that by increasing the diameter of NP say by order of 
two, the fluorescence will also increase by the same order (Fig. 2). In general, 
dye doped NPs in the range of 20-200 nm were successfully used in bioassays in 
the wider research community. As for optical imaging, the rate of uptake of 
nanoparticles by mammal cells depends on the particle size and shape. Number 
of articles emerged recently reporting that the optimum size of nanoparticles to 
enter the cells is around 50 nm. The cellular uptake of ~50 nm NP is typically the 
highest and the NPs were shown to be trapped inside vesicles in the cytoplasm, 
however did not enter the cell nucleus. Shape also plays an important role, with 
spherical nanoparticles being taken in larger numbers than rod-shaped 
nanoparticles. This is presumably due to the difference in curvature affecting the 
contact area with the cell membrane receptors. 
c) What is the desired surface modification for efficient conjugation with 
biomolecules? 
It is relatively easy to functionalize silica or polystyrene NPs with reactive groups 
that enable bioconjugation. However, each step in the conjugation process 
modifies the zeta potential of the NP, thus affecting colloidal stability. Proteins 
are usually immobilized on the surface of polystyrene beads by physical 
adsorption. It is a relatively fast method for formation of reasonably 
homogeneous protein layer. For better results, it is often desirable to block the 
non-active surface area with bovine serum albumin or similar blocking agents. In 
case of silica particles, the colloidal stability and the density of the active 
molecules on the surface can be fine-tuned by carefully executed surface 
chemistry. Some aspects of the surface modification strategies of dye doped 
silica NP will be discussed later in this chapter. 
Basic Methodology 
 
Synthesis of dye doped silica nanoparticles 
One obvious advantage of using silica particles as opposed to polystyrene is the 
significantly higher density of fused silica (2.2 – 2.6 g/cm3), which facilitates the 
manipulation and purification of samples (centrifugation at 15,000 rpm for 1-2 
minutes is usually sufficient to separate the beads from supernatant). Also, silica 
NPs are relatively non-toxic and chemically inert. They can be prepared in range 
of sizes and the post synthetic surface modification can be achieved with good 
reproducibility. 
There are two main methods for synthesis of dye-doped silica particles. 
1. Sol – gel technique via Stober method, which consists of the hydrolysis of a 
silica alkoxide precursor (such as tetraethylorthosilicate, TEOS) in an ethanol 
and aqueous ammonium hydroxide mixture. 
2. Reverse microemulsion method based on a water-in-oil reverse microemulsion 
system.  
Both methods have certain advantages and disadvantages. For example, the 
former method is comparatively simple and both organic and inorganic dyes can 
be incorporated in the silica matrix. A modified Stober method has been used to 
produce highly fluorescent dye-doped core-shell silica NPs with narrow size 
distribution by the Wiesner group at Cornell University (NY, USA)(5). The latter 
technique is using stabilized water nanodroplets formed in the oil solution. Silane 
hydrolysis and the formation of NPs with the dye trapped inside occur inside such 
small microreactors. The size of the NP is determined by the nature of surfactant, 
the hydrolysis agent, and other parameters, such as the reaction time, oil/water 
ratio, etc. The resulting NPs usually show high degree of uniformity and water 
dispersity. One of the limitations of this method is that, in most cases, it works 
well with inorganic dyes, some of which have lower quantum yields compared to 
organic fluorophores. By both techniques, the dye molecule can be either 
physically adsorbed inside the pores of NP or covalently linked to its matrix. The 
second option is preferred, as the non-covalently attached fluorophores can 
eventually diffuse or ‘leach-out’ into a solution over time, thus reducing the 
overall brightness of the NP. 
 
Surface functionalization of dye doped NPs. 
In general, the benefits of using dye doped NPs can only be realized if they are 
efficiently coated with biorecognition elements (in most cases antibody, 
oligonucleotides, etc.), have good colloidal stability and the ratio of specific to 
non-specific binding (NSB) is sufficiently great. The colloidal stability of NPs can 
be modulated by carefully executed surface modification. Sufficient separation of 
NPs can be achieved by increasing either steric or electrostatic repulsions 
between two or more adjacent NPs. Current approaches to prepare colloidal 
solutions with low polydispersity index are mostly based on electrostatic 
interactions. In polystyrene particles, the introduction of charge on the surface 
can be done by co-polymerization reaction of polystyrene monomer and its 
charged analogue. And even then, a longer term colloidal stability is guaranteed 
only after addition of polar surfactants into the sample. Quite often, this surfactant 
must be removed prior the immobilization of the antibody or DNA. On the other 
hand, the flexible silica chemistry provides versatile routes for surface 
modification. Different types of functional groups can be easily introduced onto 
the NP surface enabling conjugation with biomolecules of interest. The post-
synthetic modification of the particle surface with charged species (e.g. 
phosphates, carboxylic acid, etc.) is not only aimed to reduce particle 
aggregation but also provide some sort of reactive handle, where the reaction 
with antibodies takes place. Most of the biomolecules used as molecular 
recognition elements are charged species (proteins, DNA, etc.) and contribute 
positively towards the decrease of the polydispersity index of the sample.  
One of the most elegant and efficient methods to achieve good colloidal stability 
of silica NPs is to introduce a mixture of charged precursors on the particle 
surface. The first one is usually chemically inert with low pKa value, assuring that 
the charge is present when working at physiologically relevant pH (7.0-7.4). The 
second one, typically at much lower quantity provides reactive group for the 
reaction with biomolecules or other cross-linking agents. In 2006, Tan and 
colleagues(6) proposed a way of improving the colloidal stability of silica NPs 
through the addition of a negatively charged, non-reactive alkoxysilane with 
phosphate group along with its counterpart carrying a reactive amine. Other very 
common groups that can be used as reactive ‘handles’ include carboxylic acids, 
isothiocyanates and epoxy group. Normally, the ratio between the non-reactive 
and reactive groups is relatively high (10:1) in order to maintain the suspension 
stability. As a consequence, the number of attachment sites on the NP surface is 
therefore limited. For this reason, it might be quite difficult to achieve high protein 
coupling ratios. Gubala(7) et al overcame this disadvantage by using multivalent 
linkers such as dendrimers as antibody scaffolds (Fig.3). 
Figure 3 Structures of the most popular monovalent linkers and a cartoon 
illustrating the multivalent feature of Newkome type dendrimer, activated by 
dehydrating agent. (This figure was reprinted with permission of Elsevier). 
 
Bioconjugation strategies(8) 
As mentioned previously in this chapter, the most straightforward method to 
immobilize large biomolecules like antibodies is through physical adsorption. This 
method is very popular with polystyrene beads, however, it does not offer direct 
possibility of modulating the density of the captured protein on the NP surface. 
The control over the active surface area, which is the area of the NP surface 
covered with antibodies can be achieved by using cross-linking reagent. 
There is a great choice of commercial hetero- or homo-functional linkers 
available; however, their effect on NP stability, aggregation, solubility and 
efficiency of bioconjugation was until recently poorly documented. This was 
striking, particularly when considering that this is the actual layer “sensed” by the 
molecule to be labeled.  
Figure 4 Bioconjugation strategies that rely on the use of cross-linking agent. 
The content of –NH2 (or –NH3
+) groups on the surface of the NP is typically 
limited to ~10%. Higher amount of amines cause aggregation. The lower density 
of reactive amines is offset by the multivalency of dendrimers. Their effect is 
three fold: i) the use of dendrimers positively affects the colloidal stability of the 
NPs, ii) the reactivity of each amine on the surface is amplified by the number of 
dendrimer’s surface groups, hence significantly improving reaction efficiency with 
usually expensive biomolecules, iii) dendrimers, due to their size, not only serve 
as linkers but also as spacers between the surface of the NP and the captured 
recognition elements, thus maintaining the activity of antibodies, 
oligonucleotides, etc. The net result is more sensitive assays when compared to 
the monovalent linkers and also improved assay kinetics. 
In a sensitive and functional bioassay, one obvious issue in the use of NPs as 
labels is the fraction of the coupled antibody that is in fact active or available for 
reaction with antigen. This fraction can be rather small, which in turn can lead to 
diminished sensitivity and increased non-specific binding. The minimization of 
NSB is essential for sensitive detection in an assay. Thus, it is clear that the 
strategy used to attach an antibody to NP surface is a key element that affects 
the activity of the bound antibody, the non-specific binding and the surface 
binding of particles.  
Improved colloidal stability of silica NPs has been previously achieved by the 
addition of negatively charged non-reactive organosilanes in addition to 
organosilanes with functional groups available for bio-immobilisation. The 
number of attachment sites on the nanoparticle surface is limited in order to 
maintain the suspension stability of the NP system.  For this reason it is difficult 
to achieve high protein coupling ratios. Gubala(7) and colleagues at Biomedical 
Diagnostics Institute have recently demonstrated some advantages of using 
multivalent molecules such as dendrimers as antibody coupling scaffolds as 
illustrated on figure 3. Dendrimers are monodisperse, nano-sized, hyperbranched 
‘starburst polymers’, with growing numbers of terminal functional groups with 
increasing generation number, that have been extensively investigated for a 
variety of biomedical applications. By changing the generation of dendrimer, the 
authors were very efficiently able to control the surface area populated by 
biomolecules. The authors demonstrated that antibody-sensitized NPs prepared 
by using a multivalent linker, showed a significantly lower limit of detection and 
higher sensitivity than with the homo- and hetero-functional crosslinkers. The 
difference in performance was remarkable, particularly when compared with 
glutaraldehyde, one of the most common cross-linker still employed by many 
research laboratories. They reasoned that the multivalency of the dendrimers is 
one of the most significant factors behind the increase in the detection sensitivity. 
Dendrimers had a positive effect on NP stability and aggregation, they were more 
reactive with biological materials, capable of immobilizing antibody at the 
appropriate surface density while maintaining its activity to the analyte of interest. 
Moreover, the multivalency of the dendrimer is a significant factor responsible for 
the improvement in the reaction yields even at lower protein concentration. This 
is very important, particularly when considering the cost of the bioorganic 
material that is used in bioconjugation reactions. 
 
Dye doped nanoparticles and the implications on assay kinetics  
A surface capture immunoassay can be considered in two ways: either 
incubation of antibody-sensitised particles with antigen followed by capture onto 
an antibody-sensitised surface of those particles that have bound antigen; or 
capture of antigen onto an antibody-sensitised surface followed by capture of 
antibody-sensitised particles onto the surface-bound antigen.  In either case, the 
kinetics of reaction of a sensitised particle with a sensitised surface is a key 
element of the description of the process and hence of the assay design.  The 
size of the particles and the fraction of the particle surface that is active for the 
antibody-antigen reaction are the important parameters. A simple kinetic model 
was developed for particle capture onto an antigen-loaded assay surface by 
means of an antibody-antigen reaction. This is similar to kinetic formulations 
treating single molecules, but also accounts for the fact that each particle has a 
multiplicity of antibodies present on its surface. The NPs-surface-bound 
antibodies can be considered as active binding sites. Depending on the coverage 
of such active sites on the particle, a collision of the particle with an antigen may 
or may not lead to reaction, with a probability proportional to the surface 
coverage of active sites on the particle and the surface coverage of antigen in the 
reaction well. 
The capture reaction, of antibody-functionalised NPs onto the assay surface, can 
be written as: 
P + S  D PS  (1) 
with forward rate constant kon and reverse rate constant koff. Here, S denotes an 
active antigen site on the assay capture surface. If the NP is bound to the surface 
by a single antibody-antigen interaction, then koff will simply be the dissociation 
rate constant for the antigen-antibody complex. The association rate, kon, will be 
determined by the probability of a reactive collision between an antibody 
functionalised NP and an unoccupied reactive antigen site on the assay surface.  
A reactive collision, leading to coupling of the NP to the assay surface, would 
occur when a reactive part of the NP surface (an antibody, oriented with the 
binding site exposed) collides with a reactive part of the assay surface (an 
antigen, oriented with the epitope exposed).  NPs are in a continuous state of 
collision with the assay surface, at a rate determined by the diffusion coefficient 
of the NPs (hence by their radius and the viscosity of the reaction medium) and 
by their concentration. As the NP concentration on the assay surface builds up, 
particles not only occupy sites but also physically block the assay surface area, 
on account of their size.  The probability of obtaining a successful reactive 
collision between particle and capture surface also depends on the fraction of the 
capture surface that is active for reaction. Therefore, the probability that the 
collision will be with an active site on the assay capture surface will be a product 
of the following: 
- The fraction of the total assay capture surface that is covered by accessible 
antigen with the binding epitope correctly exposed to facilitate antibody binding;  
- The fraction of the total assay surface that is unblocked by bound NPs;  
- A coverage-dependent factor that expresses the requirement that a NP requires 
a space whose smallest dimension is at least as large as the NP diameter, in 
order that the NP can fit into the space.   
Figure 5 Top – A cartoon illustrating a bioconjugation reaction between single 
chain fragments of C-reactive protein antibody (ScFv) and dye doped silica NP. 
By varying the dendrimer generation, it is possible to vary the density of ScFv 
fragments on the surface of NP, hence modulate the active surface area of NPs. 
The net outcome is increased probability of reactive collision and hence 
association Kon constant. The effect of increased active antibody loading 
significantly outweighed any effect of a decreased NP diffusion coefficient 
compared to that of a molecular dye-labelled antibody. 
The considerations of reaction probability are embedded in the capture rate 
constant, kon, which depends on both the fraction of the surface of the antigen-
loaded capture plate that is in fact active for the capture reaction (that is, it 
depends on the surface state of the adsorbed antigen) and on the fraction of the 









    (2) 
where kD is the diffusion-limit rate constant for NP consumption by the antigen-
surface, dependent on the NP radius and the viscosity of the medium, ε is the 
reaction efficiency for a reactive collision, θS is the fraction of the capture surface 
area (here the antigen-loaded capture plate) that is active for the capture 
reaction, which in this case is dependent on the surface coverage of active 
adsorbed antigen on the prepared capture surface, and θP is the active fraction of 
the NP surface, in this case dependent on the surface coverage of active 
antibody attached to the NP. Therefore, the central objective of surface 
functionalisation with is to increase θP, which can be achieved by using 
dendrimer as linker.  
Gubala et al have shown how the use of dendrimers as multivalent linkers 
effectively controls and maximizes the active fraction of the particle surface.  
Dendrimers have been presented as efficient coupling agents to conjugate 
antibodies to the surface of dye-doped silica nanoparticles. The protein binding 
capacity of the dendrimer-sensitised NPs increased by the same factor as the 
number of surface carboxylate groups on the dendrimer used. The highest 
generation of the dendrimers (G4.5) used in their study showed the highest 
surface binding rate and the highest signal in the direct binding FLISA. The effect 
of increased active antibody loading significantly outweighed any effect of a 
decreased NP diffusion coefficient compared to that of a molecular dye-labeled 
antibody. The practically important parameter, the ratio of the equilibrium 
fluorescence (offset corrected) to the non-specific offset, or signal to background 
ratio, increased by a factor of ~4 for the G4.5 dendrimer-conjugated NPs 
compared to the molecular dye-labeled antibody.  
 
Future directions 
Successful detection devices for biomedical diagnostics frequently require high 
sensitivity and low LOD. Moreover, a device for point-of-care diagnostics must be 
both inexpensive and reliable under a variety of experimental conditions. In this 
chapter the advantages of employing dielectric, dye doped NPs have been 
highlighted for the purpose of enhancing the performance of fluorescence-based 
assays. The objective of this chapter was to discuss the versatility of silica (or 
eventually polystyrene) as a host material for fluorescent dyes for many 
applications, specifically in the fields of nanobiotechnology and the life sciences. 
Silica as a host material represents an ideal scaffold for encapsulation of organic 
dyes in a silica matrix thus enhancing their stability and performance.  
It is obvious from the growing literature on this topic that this area is still in a 
growth phase and that significant new developments are likely to emerge in the 
coming decades. Although co-doping of NPs with multiple dyes of distinguishable 
spectral properties has been demonstrated, the application of such barcoding 
NPs in multiplexed assays is expected to grow significantly. Similarly, the use of 
high-brightness NPs as labels in flow cytometry applications is attracting 
considerable interest. The versatility of silica as a host material and the feasibility 
to modulate the core–shell architecture provide a unique environment for 
innovative research towards creating integrated nanomaterials with highly fine-
tuned functionality in the field of nanotechnology and beyond. 
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